25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

PIQ (Proteomics) Stock Analysis
Buy, Hold or Sell?

Let's analyze Proteomics together

I guess you are interested in Proteomics International Laboratories Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – Proteomics’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – Proteomics’s Price Targets

I'm going to help you getting a better view of Proteomics International Laboratories Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Proteomics International Laboratories Ltd

I send you an email if I find something interesting about Proteomics International Laboratories Ltd.

1. Quick Overview

1.1. Quick analysis of Proteomics (30 sec.)










1.2. What can you expect buying and holding a share of Proteomics? (30 sec.)

How much money do you get?

How much money do you get?
A$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
A$0.06
Expected worth in 1 year
A$0.08
How sure are you?
60.0%

+ What do you gain per year?

Total Gains per Share
A$0.02
Return On Investment
6.2%

For what price can you sell your share?

Current Price per Share
A$0.37
Expected price per share
A$0 - A$0.36
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Proteomics (5 min.)




Live pricePrice per Share (EOD)
A$0.37
Intrinsic Value Per Share
A$-0.52 - A$-0.30
Total Value Per Share
A$-0.46 - A$-0.24

2.2. Growth of Proteomics (5 min.)




Is Proteomics growing?

Current yearPrevious yearGrowGrow %
How rich?$6m$5.4m$609.3k10.0%

How much money is Proteomics making?

Current yearPrevious yearGrowGrow %
Making money-$4.1m-$4.1m-$93.3k-2.2%
Net Profit Margin-714.7%-853.6%--

How much money comes from the company's main activities?

2.3. Financial Health of Proteomics (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#638 / 884

Most Revenue
#494 / 884

Most Profit
#387 / 884

Most Efficient
#683 / 884
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Proteomics?

Welcome investor! Proteomics's management wants to use your money to grow the business. In return you get a share of Proteomics.

First you should know what it really means to hold a share of Proteomics. And how you can make/lose money.

Speculation

The Price per Share of Proteomics is A$0.365. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Proteomics.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Proteomics, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is A$0.06. Based on the TTM, the Book Value Change Per Share is A$0.01 per quarter. Based on the YOY, the Book Value Change Per Share is A$0.03 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is A$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Proteomics.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 A$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per Share
Usd Eps-0.03-7.0%-0.03-7.0%-0.02-6.8%-0.02-6.4%-0.02-4.9%-0.01-3.2%
Usd Book Value Change Per Share0.001.0%0.001.0%0.025.4%0.000.6%0.011.4%0.000.5%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.001.0%0.001.0%0.025.4%0.000.6%0.011.4%0.000.5%
Usd Price Per Share0.58-0.58-0.57-0.59-0.53-0.35-
Price to Earnings Ratio-22.57--22.57--22.77--25.31--33.64--32.78-
Price-to-Total Gains Ratio155.41-155.41-28.53-49.29-48.57-18.99-
Price to Book Ratio15.56-15.56-16.90-25.75-22.52-24.05-
Price-to-Total Gains Ratio155.41-155.41-28.53-49.29-48.57-18.99-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.2402065
Number of shares4163
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.01
Usd Total Gains Per Share0.000.01
Gains per Quarter (4163 shares)15.5120.99
Gains per Year (4163 shares)62.0583.94
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10625208474
201241140168158
301861760252242
402482380336326
503103000420410
603723620504494
704344240588578
804964860672662
905585480755746
1006216100839830

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.010.00.00.0%0.011.00.00.0%
Book Value Change Per Share1.00.00.0100.0%2.01.00.066.7%4.01.00.080.0%6.04.00.060.0%7.04.00.063.6%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.010.00.0%0.00.011.00.0%
Total Gains per Share1.00.00.0100.0%2.01.00.066.7%4.01.00.080.0%6.04.00.060.0%7.04.00.063.6%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Proteomics International Laboratories Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0060.0060%0.030-81%0.003+69%0.008-26%0.003+115%
Book Value Per Share--0.0570.0570%0.051+11%0.043+32%0.040+40%0.027+106%
Current Ratio--10.12710.1270%7.551+34%6.747+50%7.255+40%6.602+53%
Debt To Asset Ratio--0.1500.1500%0.174-14%0.231-35%0.202-26%0.258-42%
Debt To Equity Ratio--0.1730.1730%0.209-17%0.324-47%0.271-36%0.399-57%
Dividend Per Share----0%-0%-0%-0%-0%
Enterprise Value--148912791.960148912791.9600%144903245.120+3%148666599.213+0%134359675.976+11%88972868.136+67%
Eps---0.039-0.0390%-0.038-3%-0.036-8%-0.027-31%-0.018-54%
Ev To Ebitda Ratio---17.734-17.7340%-19.183+8%-23.429+32%-33.530+89%-34.192+93%
Ev To Sales Ratio--166.916166.9160%198.405-16%155.835+7%127.111+31%87.863+90%
Free Cash Flow Per Share---0.037-0.0370%-0.042+15%-0.034-8%-0.026-30%-0.017-54%
Free Cash Flow To Equity Per Share--0.0040.0040%0.024-85%0.002+85%0.006-41%0.003+7%
Gross Profit Margin--1.6001.6000%1.000+60%1.208+32%1.138+41%1.118+43%
Intrinsic Value_10Y_max---0.300----------
Intrinsic Value_10Y_min---0.519----------
Intrinsic Value_1Y_max---0.020----------
Intrinsic Value_1Y_min---0.039----------
Intrinsic Value_3Y_max---0.067----------
Intrinsic Value_3Y_min---0.129----------
Intrinsic Value_5Y_max---0.124----------
Intrinsic Value_5Y_min---0.231----------
Market Cap59685162.080-141%143898472.960143898472.9600%140628053.120+2%145533682.880-1%131307356.576+10%87156688.736+65%
Net Profit Margin---7.147-7.1470%-8.536+19%-6.341-11%-4.486-37%-2.958-59%
Operating Margin---10.228-10.2280%-11.068+8%-8.213-20%-5.697-44%-3.577-65%
Operating Ratio--11.77811.7780%16.283-28%11.696+1%8.813+34%5.646+109%
Pb Ratio6.453-141%15.55815.5580%16.896-8%25.754-40%22.523-31%24.052-35%
Pe Ratio-9.361+59%-22.568-22.5680%-22.768+1%-25.305+12%-33.639+49%-32.778+45%
Price Per Share0.365-141%0.8800.8800%0.860+2%0.890-1%0.803+10%0.533+65%
Price To Free Cash Flow Ratio-9.954+59%-23.997-23.9970%-20.349-15%-28.597+19%-36.659+53%-37.310+55%
Price To Total Gains Ratio64.460-141%155.409155.4090%28.528+445%49.288+215%48.574+220%18.990+718%
Quick Ratio--7.5417.5410%5.654+33%4.898+54%5.353+41%5.052+49%
Return On Assets---0.586-0.5860%-0.619+6%-0.709+21%-0.555-5%-0.520-11%
Return On Equity---0.677-0.6770%-0.744+10%-0.962+42%-0.731+8%-0.754+11%
Total Gains Per Share--0.0060.0060%0.030-81%0.003+69%0.008-26%0.003+115%
Usd Book Value--6086889.9656086889.9650%5477534.774+11%4599304.053+32%4345251.085+40%2953741.872+106%
Usd Book Value Change Per Share--0.0040.0040%0.020-81%0.002+69%0.005-26%0.002+115%
Usd Book Value Per Share--0.0370.0370%0.033+11%0.028+32%0.027+40%0.018+106%
Usd Dividend Per Share----0%-0%-0%-0%-0%
Usd Enterprise Value--97999508.38997999508.3890%95360825.613+3%97837488.942+0%88422102.760+11%58553044.520+67%
Usd Eps---0.026-0.0260%-0.025-3%-0.024-8%-0.018-31%-0.012-54%
Usd Free Cash Flow---3946229.524-3946229.5240%-4548011.300+15%-3636362.261-8%-2758955.262-30%-1817629.424-54%
Usd Free Cash Flow Per Share---0.024-0.0240%-0.028+15%-0.022-8%-0.017-30%-0.011-54%
Usd Free Cash Flow To Equity Per Share--0.0020.0020%0.016-85%0.001+85%0.004-41%0.002+7%
Usd Market Cap39278805.165-141%94699585.05594699585.0550%92547321.758+2%95775716.703-1%86413371.363+10%57357816.857+65%
Usd Price Per Share0.240-141%0.5790.5790%0.566+2%0.586-1%0.528+10%0.351+65%
Usd Profit---4196189.724-4196189.7240%-4102799.411-2%-3857231.370-8%-2920242.674-30%-1915165.635-54%
Usd Revenue--587119.308587119.3080%480636.754+22%682626.510-14%769411.034-24%713434.956-18%
Usd Total Gains Per Share--0.0040.0040%0.020-81%0.002+69%0.005-26%0.002+115%
 EOD+2 -6MRQTTM+0 -0YOY+26 -123Y+23 -155Y+18 -2010Y+24 -14

3.3 Fundamental Score

Let's check the fundamental score of Proteomics International Laboratories Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-9.361
Price to Book Ratio (EOD)Between0-16.453
Net Profit Margin (MRQ)Greater than0-7.147
Operating Margin (MRQ)Greater than0-10.228
Quick Ratio (MRQ)Greater than17.541
Current Ratio (MRQ)Greater than110.127
Debt to Asset Ratio (MRQ)Less than10.150
Debt to Equity Ratio (MRQ)Less than10.173
Return on Equity (MRQ)Greater than0.15-0.677
Return on Assets (MRQ)Greater than0.05-0.586
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Proteomics International Laboratories Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5050.973
Ma 20Greater thanMa 500.361
Ma 50Greater thanMa 1000.377
Ma 100Greater thanMa 2000.451
OpenGreater thanClose0.330
Total1/5 (20.0%)

4. In-depth Analysis

4.1 About Proteomics International Laboratories Ltd

Proteomics International Laboratories Ltd operates as a medical technology company with a focus on the area of proteomics in Australia, New Zealand, the United States, Europe, India, and South East Asia. It provides PromarkerD, a protein-based diagnostic blood test to predict diabetic kidney disease (DKD). The company's products under development include PromarkerEndo, which has completed clinical validation phase for endometriosis diagnosis; PromarkerEso, that has completed clinical validation trials for esophageal cancer diagnosis; and OxiDx (2-tag), which has completed clinical validation phase for oxidative stress treatment. It is also developing diagnostic tests for that includes DKD - T1D, that is under clinical phase for diabetic kidney disease in type 1 diabetes; Asthma and COPD, which has completed proof-of-concept study trials for asthma and chronic obstructive pulmonary disease; Plant Dieback, that is under development phase for phytophthora dieback; Diabetic Retinopathy, which has completed discovery phase for sight-threatening retinopathy; Diabetic Neuropathy, that is under research phase to investigate predictive biomarkers for diabetic neuropathy; and Giardia, a causing gastroenteritis. The company also offers analytical services, such as pharmacokinetic testing, biomarker discovery, protein analysis, project consultation, and specialist contract research. Proteomics International Laboratories Ltd was founded in 2001 and is headquartered in Perth, Australia.

Fundamental data was last updated by Penke on 2025-07-02 03:46:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ Proteomics earns for each $1 of revenue.

  • Above 10% is considered healthy but always compareΒ Proteomics to theΒ Biotechnology industry mean.
  • A Net Profit Margin of -714.7%Β means thatΒ $-7.15 for each $1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Proteomics International Laboratories Ltd:

  • The MRQ is -714.7%. The company is making a huge loss. -2
  • The TTM is -714.7%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-714.7%TTM-714.7%0.0%
TTM-714.7%YOY-853.6%+138.9%
TTM-714.7%5Y-448.6%-266.1%
5Y-448.6%10Y-295.8%-152.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-714.7%-92.7%-622.0%
TTM-714.7%-141.4%-573.3%
YOY-853.6%-186.1%-667.5%
3Y-634.1%-248.3%-385.8%
5Y-448.6%-338.6%-110.0%
10Y-295.8%-488.9%+193.1%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ Proteomics is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ Proteomics to theΒ Biotechnology industry mean.
  • -58.6% Return on Assets means thatΒ Proteomics generatedΒ $-0.59 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Proteomics International Laboratories Ltd:

  • The MRQ is -58.6%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -58.6%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-58.6%TTM-58.6%0.0%
TTM-58.6%YOY-61.9%+3.2%
TTM-58.6%5Y-55.5%-3.2%
5Y-55.5%10Y-52.0%-3.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-58.6%-11.5%-47.1%
TTM-58.6%-11.6%-47.0%
YOY-61.9%-11.4%-50.5%
3Y-70.9%-11.8%-59.1%
5Y-55.5%-12.1%-43.4%
10Y-52.0%-13.8%-38.2%
4.3.1.3. Return on Equity

Shows how efficient Proteomics is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ Proteomics to theΒ Biotechnology industry mean.
  • -67.7% Return on Equity means Proteomics generated $-0.68Β for eachΒ $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Proteomics International Laboratories Ltd:

  • The MRQ is -67.7%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -67.7%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-67.7%TTM-67.7%0.0%
TTM-67.7%YOY-74.4%+6.6%
TTM-67.7%5Y-73.1%+5.4%
5Y-73.1%10Y-75.4%+2.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-67.7%-13.6%-54.1%
TTM-67.7%-14.9%-52.8%
YOY-74.4%-14.4%-60.0%
3Y-96.2%-17.0%-79.2%
5Y-73.1%-17.9%-55.2%
10Y-75.4%-20.1%-55.3%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Proteomics International Laboratories Ltd.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient Proteomics is operatingΒ .

  • Measures how much profit Proteomics makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ Proteomics to theΒ Biotechnology industry mean.
  • An Operating Margin of -1,022.8%Β means the company generated $-10.23 Β for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Proteomics International Laboratories Ltd:

  • The MRQ is -1,022.8%. The company is operating very inefficient. -2
  • The TTM is -1,022.8%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-1,022.8%TTM-1,022.8%0.0%
TTM-1,022.8%YOY-1,106.8%+84.0%
TTM-1,022.8%5Y-569.7%-453.1%
5Y-569.7%10Y-357.7%-212.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-1,022.8%-229.2%-793.6%
TTM-1,022.8%-250.3%-772.5%
YOY-1,106.8%-205.1%-901.7%
3Y-821.3%-220.2%-601.1%
5Y-569.7%-342.6%-227.1%
10Y-357.7%-475.5%+117.8%
4.3.2.2. Operating Ratio

Measures how efficient Proteomics is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Biotechnology industry mean).
  • An Operation Ratio of 11.78 means that the operating costs are $11.78 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Proteomics International Laboratories Ltd:

  • The MRQ is 11.778. The company is inefficient in keeping operating costs low. -1
  • The TTM is 11.778. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ11.778TTM11.7780.000
TTM11.778YOY16.283-4.505
TTM11.7785Y8.813+2.965
5Y8.81310Y5.646+3.168
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ11.7782.110+9.668
TTM11.7782.704+9.074
YOY16.2833.063+13.220
3Y11.6963.576+8.120
5Y8.8134.713+4.100
10Y5.6466.512-0.866
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Proteomics International Laboratories Ltd.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Proteomics is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Biotechnology industry mean).
  • A Current Ratio of 10.13Β means the company has $10.13 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Proteomics International Laboratories Ltd:

  • The MRQ is 10.127. The company is very able to pay all its short-term debts. +2
  • The TTM is 10.127. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ10.127TTM10.1270.000
TTM10.127YOY7.551+2.576
TTM10.1275Y7.255+2.872
5Y7.25510Y6.602+0.653
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ10.1273.661+6.466
TTM10.1273.786+6.341
YOY7.5514.121+3.430
3Y6.7474.680+2.067
5Y7.2555.765+1.490
10Y6.6026.150+0.452
4.4.3.2. Quick Ratio

Measures if Proteomics is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ Proteomics to theΒ Biotechnology industry mean.
  • A Quick Ratio of 7.54Β means the company can pay off $7.54 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Proteomics International Laboratories Ltd:

  • The MRQ is 7.541. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 7.541. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ7.541TTM7.5410.000
TTM7.541YOY5.654+1.887
TTM7.5415Y5.353+2.188
5Y5.35310Y5.052+0.300
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ7.5412.826+4.715
TTM7.5413.128+4.413
YOY5.6543.782+1.872
3Y4.8984.304+0.594
5Y5.3535.703-0.350
10Y5.0526.454-1.402
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Proteomics International Laboratories Ltd.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of ProteomicsΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ Proteomics to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.15Β means that Proteomics assets areΒ financed with 15.0% credit (debt) and the remaining percentage (100% - 15.0%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of Proteomics International Laboratories Ltd:

  • The MRQ is 0.150. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.150. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.150TTM0.1500.000
TTM0.150YOY0.174-0.024
TTM0.1505Y0.202-0.053
5Y0.20210Y0.258-0.056
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1500.324-0.174
TTM0.1500.347-0.197
YOY0.1740.327-0.153
3Y0.2310.339-0.108
5Y0.2020.349-0.147
10Y0.2580.382-0.124
4.5.4.2. Debt to Equity Ratio

Measures ifΒ Proteomics is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ Proteomics to theΒ Biotechnology industry mean.
  • A Debt to Equity ratio of 17.3% means that company has $0.17 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Proteomics International Laboratories Ltd:

  • The MRQ is 0.173. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.173. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.173TTM0.1730.000
TTM0.173YOY0.209-0.036
TTM0.1735Y0.271-0.098
5Y0.27110Y0.399-0.128
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1730.383-0.210
TTM0.1730.436-0.263
YOY0.2090.410-0.201
3Y0.3240.446-0.122
5Y0.2710.460-0.189
10Y0.3990.509-0.110
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every $1 in earnings Proteomics generates.

  • Above 15 is considered overpriced butΒ always compareΒ Proteomics to theΒ Biotechnology industry mean.
  • A PE ratio of -22.57 means the investor is paying $-22.57Β for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Proteomics International Laboratories Ltd:

  • The EOD is -9.361. Based on the earnings, the company is expensive. -2
  • The MRQ is -22.568. Based on the earnings, the company is expensive. -2
  • The TTM is -22.568. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-9.361MRQ-22.568+13.207
MRQ-22.568TTM-22.5680.000
TTM-22.568YOY-22.768+0.200
TTM-22.5685Y-33.639+11.071
5Y-33.63910Y-32.778-0.861
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-9.361-2.197-7.164
MRQ-22.568-2.027-20.541
TTM-22.568-2.527-20.041
YOY-22.768-3.733-19.035
3Y-25.305-3.717-21.588
5Y-33.639-6.036-27.603
10Y-32.778-6.649-26.129
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Proteomics International Laboratories Ltd:

  • The EOD is -9.954. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -23.997. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -23.997. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-9.954MRQ-23.997+14.044
MRQ-23.997TTM-23.9970.000
TTM-23.997YOY-20.349-3.649
TTM-23.9975Y-36.659+12.661
5Y-36.65910Y-37.310+0.651
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-9.954-3.007-6.947
MRQ-23.997-2.704-21.293
TTM-23.997-3.627-20.370
YOY-20.349-4.334-16.015
3Y-28.597-5.070-23.527
5Y-36.659-8.532-28.127
10Y-37.310-9.305-28.005
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ Proteomics is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Biotechnology industry mean).
  • A PB ratio of 15.56 means the investor is paying $15.56Β for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Proteomics International Laboratories Ltd:

  • The EOD is 6.453. Based on the equity, the company is overpriced. -1
  • The MRQ is 15.558. Based on the equity, the company is expensive. -2
  • The TTM is 15.558. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD6.453MRQ15.558-9.105
MRQ15.558TTM15.5580.000
TTM15.558YOY16.896-1.338
TTM15.5585Y22.523-6.965
5Y22.52310Y24.052-1.529
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD6.4531.921+4.532
MRQ15.5581.843+13.715
TTM15.5582.113+13.445
YOY16.8962.467+14.429
3Y25.7542.541+23.213
5Y22.5233.666+18.857
10Y24.0524.311+19.741
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Proteomics International Laboratories Ltd.

3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2020-06-302021-06-302022-06-302023-06-302024-06-30
Inventory  5773130-478436119-2,342-2,223



5.2. Latest Balance Sheet

Balance Sheet of 2024-06-30. Currency in AUD. All numbers in thousands.

Summary
Total Assets10,875
Total Liabilities1,626
Total Stockholder Equity9,413
 As reported
Total Liabilities 1,626
Total Stockholder Equity+ 9,413
Total Assets = 10,875

Assets

Total Assets10,875
Total Current Assets9,165
Long-term Assets1,710
Total Current Assets
Cash And Cash Equivalents 6,640
Net Receivables 184
Other Current Assets 2,340
Total Current Assets  (as reported)9,165
Total Current Assets  (calculated)9,165
+/-0
Long-term Assets
Property Plant Equipment 1,709
Intangible Assets 1
Other Assets 0
Long-term Assets  (as reported)1,710
Long-term Assets  (calculated)1,710
+/- 0

Liabilities & Shareholders' Equity

Total Current Liabilities905
Long-term Liabilities721
Total Stockholder Equity9,413
Total Current Liabilities
Short-term Debt 95
Accounts payable 58
Other Current Liabilities 503
Total Current Liabilities  (as reported)905
Total Current Liabilities  (calculated)656
+/- 249
Long-term Liabilities
Capital Lease Obligations 316
Long-term Liabilities  (as reported)721
Long-term Liabilities  (calculated)316
+/- 405
Total Stockholder Equity
Common Stock36,810
Retained Earnings -29,671
Accumulated Other Comprehensive Income 2,274
Total Stockholder Equity (as reported)9,413
Total Stockholder Equity (calculated)9,413
+/-0
Other
Capital Stock36,810
Cash and Short Term Investments 6,640
Common Stock Shares Outstanding 125,849
Current Deferred Revenue249
Liabilities and Stockholders Equity 10,875
Net Debt -6,324
Net Invested Capital 9,413
Net Working Capital 8,260
Property Plant and Equipment Gross 4,457
Short Long Term Debt Total 316



5.3. Balance Sheets Structured

Currency in AUD. All numbers in thousands.

 Trend2024-06-302023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-30
> Total Assets 
5,234
2,532
1,623
2,889
5,495
3,621
5,555
8,600
5,396
10,075
10,875
10,87510,0755,3968,6005,5553,6215,4952,8891,6232,5325,234
   > Total Current Assets 
5,218
2,522
1,601
2,377
3,792
3,243
4,118
7,338
4,362
8,327
9,165
9,1658,3274,3627,3384,1183,2433,7922,3771,6012,5225,218
       Cash And Cash Equivalents 
4,955
2,005
582
775
2,317
1,511
2,365
5,605
2,112
6,027
6,640
6,6406,0272,1125,6052,3651,5112,3177755822,0054,955
       Net Receivables 
214
196
142
318
1,447
1,641
463
259
440
208
184
1842084402594631,6411,447318142196214
       Other Current Assets 
49
321
877
1,248
873
1,321
1,290
1,474
1,727
1,972
2,340
2,3401,9721,7271,4741,2901,3218731,24887732149
   > Long-term Assets 
16
10
21
512
1,703
378
1,437
1,262
1,034
1,749
1,710
1,7101,7491,0341,2621,4373781,703512211016
       Property Plant Equipment 
15
9
20
511
524
214
1,436
1,261
973
1,688
1,709
1,7091,6889731,2611,43621452451120915
       Long Term Investments 
0
0
0
0
1,178
164
0
0
0
0
0
000001641,1780000
       Intangible Assets 
1
1
1
1
1
1
1
1
1
1
1
11111111111
       Long-term Assets Other 
0
0
21
512
160
-215
-1,437
-1,262
60
60
0
06060-1,262-1,437-2151605122100
> Total Liabilities 
294
727
831
1,279
818
635
1,117
990
2,002
1,752
1,626
1,6261,7522,0029901,1176358181,279831727294
   > Total Current Liabilities 
294
275
368
579
611
549
622
779
1,702
1,103
905
9051,1031,702779622549611579368275294
       Short-term Debt 
15
442
442
219
148
140
-124
69
356
31
95
953135669-12414014821944244215
       Short Long Term Debt 
457
442
442
875
312
0
0
0
0
0
0
000000312875442442457
       Accounts payable 
199
82
125
136
126
225
182
142
517
154
58
5815451714218222512613612582199
       Other Current Liabilities 
79
193
242
224
338
171
189
297
1,185
549
503
5035491,18529718917133822424219379
   > Long-term Liabilities 
442
452
463
700
207
86
494
211
301
649
721
72164930121149486207700463452442
       Long term Debt Total 
0
0
0
656
165
18
69
0
0
34
0
034006918165656000
       Long term Debt 
442
442
442
366
165
0
0
0
0
0
0
000000165366442442442
       Capital Lease Obligations 
0
0
0
509
312
165
133
69
0
64
316
31664069133165312509000
       Other Liabilities 
0
10
22
44
42
67
425
211
301
0
0
0030121142567424422100
> Total Stockholder Equity
4,941
1,805
791
1,610
4,676
2,986
4,438
7,609
3,394
8,381
9,413
9,4138,3813,3947,6094,4382,9864,6761,6107911,8054,941
   Common Stock
6,189
4,044
4,049
5,935
10,370
10,537
13,392
19,095
19,341
30,180
36,810
36,81030,18019,34119,09513,39210,53710,3705,9354,0494,0446,189
   Retained Earnings -29,671-23,628-17,630-12,657-10,008-8,264-6,184-4,744-3,827-2,499-1,443
   Accumulated Other Comprehensive Income 
194
260
570
418
490
713
1,054
1,171
1,683
1,828
2,274
2,2741,8281,6831,1711,054713490418570260194
   Capital Surplus 00000000000
   Treasury Stock00000000000



5.4. Balance Sheets

Currency in AUD. All numbers in thousands.




5.5. Cash Flows

Currency in AUD. All numbers in thousands.




5.6. Income Statements

Currency in AUD. All numbers in thousands.


5.7. Latest Income Statement

Income Statement (annual), 2024-06-30. Currency in AUD. All numbers in thousands.

Gross Profit (+$)
totalRevenue892
Cost of Revenue-2,015
Gross Profit-1,123-1,123
 
Operating Income (+$)
Gross Profit-1,123
Operating Expense-8,493
Operating Income-9,125-9,616
 
Operating Expense (+$)
Research Development1,830
Selling General Administrative5,551
Selling And Marketing Expenses3,828
Operating Expense8,49311,208
 
Net Interest Income (+$)
Interest Income282
Interest Expense-23
Other Finance Cost-0
Net Interest Income259
 
Pretax Income (+$)
Operating Income-9,125
Net Interest Income259
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-8,638-9,611
EBIT - interestExpense = -9,148
-8,533
-6,353
Interest Expense23
Earnings Before Interest and Taxes (EBIT)-9,125-8,615
Earnings Before Interest and Taxes (EBITDA)-8,397
 
After tax Income (+$)
Income Before Tax-8,638
Tax Provision-0
Net Income From Continuing Ops-6,482-8,638
Net Income-6,376
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses10,508
Total Other Income/Expenses Net487-259
 

Technical Analysis of Proteomics
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Proteomics. The general trend of Proteomics is BEARISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Proteomics's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-85.7%) Bearish trend (85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Proteomics Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Proteomics International Laboratories Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 0.355 < 0.36 < 0.36.

The bearish price targets are: .

Know someone who trades $PIQ? Share this with them.πŸ‘‡

Proteomics International Laboratories Ltd Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Proteomics International Laboratories Ltd. The current mas is .

The long score for the Moving Averages is 1/14.
The longshort score for the Moving Averages is -12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Proteomics International Laboratories Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Proteomics International Laboratories Ltd. The current macd is -0.0205874.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Proteomics price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Proteomics. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Proteomics price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Proteomics International Laboratories Ltd Daily Moving Average Convergence/Divergence (MACD) ChartProteomics International Laboratories Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Proteomics International Laboratories Ltd. The current adx is 23.96.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Proteomics shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Proteomics International Laboratories Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Proteomics International Laboratories Ltd. The current sar is 0.285.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Proteomics International Laboratories Ltd Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Proteomics International Laboratories Ltd. The current rsi is 50.97. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending up: The RSI is trending up. +1
Proteomics International Laboratories Ltd Daily Relative Strength Index (RSI) ChartProteomics International Laboratories Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Proteomics International Laboratories Ltd. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Proteomics price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Proteomics International Laboratories Ltd Daily Stochastic Oscillator ChartProteomics International Laboratories Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Proteomics International Laboratories Ltd. The current cci is -17.50465549.

Proteomics International Laboratories Ltd Daily Commodity Channel Index (CCI) ChartProteomics International Laboratories Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Proteomics International Laboratories Ltd. The current cmo is 12.45.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Proteomics International Laboratories Ltd Daily Chande Momentum Oscillator (CMO) ChartProteomics International Laboratories Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Proteomics International Laboratories Ltd. The current willr is -27.27272727.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Proteomics is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Proteomics International Laboratories Ltd Daily Williams %R ChartProteomics International Laboratories Ltd Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of Proteomics International Laboratories Ltd.

Proteomics International Laboratories Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Proteomics International Laboratories Ltd. The current atr is 0.02435143.

Proteomics International Laboratories Ltd Daily Average True Range (ATR) ChartProteomics International Laboratories Ltd Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Proteomics International Laboratories Ltd. The current obv is -3,356,409.

Proteomics International Laboratories Ltd Daily On-Balance Volume (OBV) ChartProteomics International Laboratories Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Proteomics International Laboratories Ltd. The current mfi is 19.78.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Proteomics International Laboratories Ltd Daily Money Flow Index (MFI) ChartProteomics International Laboratories Ltd Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Proteomics International Laboratories Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-02-07STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-11WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-17STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-18STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-02-20CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-21STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-24MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-25STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-26STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-28STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-04STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-06STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-10STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-11MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-03-12RSI LONG ENTRY SHORT CLOSE30 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-03-13SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-03-14STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-18MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-19STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-03-20MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-03-25SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-28STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-31STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-04-02CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-03STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-04-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-07STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-04-08RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-04-10MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-04-11SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-04-15STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-23SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-04-24STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-28STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-01RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-05STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-07STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-05-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-09MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-05-19STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-22WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-26STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-28STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-05-29STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-30WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-06-03CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-06-05DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-06MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-06-10SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-06-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-06-13CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-06-16STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-06-18STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-20STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-23BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-24STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-25STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-26STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-27MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-06-30RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-01SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).

6.3. Candlestick Patterns

Proteomics International Laboratories Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Proteomics International Laboratories Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5050.973
Ma 20Greater thanMa 500.361
Ma 50Greater thanMa 1000.377
Ma 100Greater thanMa 2000.451
OpenGreater thanClose0.330
Total1/5 (20.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Proteomics with someone you think should read this too:
  • Are you bullish or bearish on Proteomics? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Proteomics? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Proteomics International Laboratories Ltd

I send you an email if I find something interesting about Proteomics International Laboratories Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Proteomics International Laboratories Ltd.

Receive notifications about Proteomics International Laboratories Ltd in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.